Rule, Simon <br/><br/>
Subcutaneous vs intravenous rituximab in patients with non-Hodgkin lymphoma: a time and motion study in the United Kingdom.  [electronic resource] 

 -  Journal of medical economics  Jul 2014 
 - 459-68 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1941-837X 
<br/><br/><label>Standard No.: </label>10.3111/13696998.2014.914033  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Intravenous--economics<br/>Antibodies, Monoclonal, Murine-Derived--administration & dosage<br/>Antineoplastic Agents--administration & dosage<br/>Clinical Trials, Phase III as Topic<br/>Costs and Cost Analysis<br/>Health Personnel--economics<br/>Humans<br/>Injections, Subcutaneous--economics<br/>Lymphoma, Non-Hodgkin--drug therapy<br/>Outpatient Clinics, Hospital--economics<br/>Prospective Studies<br/>Rituximab<br/>State Medicine--economics<br/>Time and Motion Studies<br/>United Kingdom